ROMANO, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.188
AS - Asia 263
EU - Europa 260
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 3.716
Nazione #
US - Stati Uniti d'America 3.184
CN - Cina 201
IT - Italia 88
FI - Finlandia 54
VN - Vietnam 41
SE - Svezia 31
GB - Regno Unito 30
DE - Germania 20
IN - India 9
IE - Irlanda 7
NL - Olanda 7
UA - Ucraina 7
TR - Turchia 5
CA - Canada 4
CZ - Repubblica Ceca 4
FR - Francia 4
TW - Taiwan 4
ES - Italia 3
NZ - Nuova Zelanda 3
DK - Danimarca 2
JP - Giappone 2
BE - Belgio 1
BR - Brasile 1
HU - Ungheria 1
IR - Iran 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 3.716
Città #
Fairfield 609
Woodbridge 354
Houston 268
Chandler 261
Ashburn 246
Cambridge 231
Seattle 224
Ann Arbor 202
Wilmington 198
San Diego 62
Beijing 49
Princeton 48
Dong Ket 41
Medford 38
Des Moines 37
Jacksonville 35
Roxbury 33
Padova 32
Helsinki 31
Nanjing 31
Boardman 22
Dearborn 18
Guangzhou 14
Shenyang 13
New York 12
Falls Church 11
Hefei 11
Nanchang 11
Cologno Monzese 8
Hebei 8
Dublin 7
Cagliari 6
Zhengzhou 6
Bologna 5
Jinan 5
Paris 4
Taizhou 4
Wuhan 4
Yenibosna 4
Amsterdam 3
Changsha 3
Chicago 3
Detroit 3
Jiaxing 3
Kaohsiung City 3
Kilburn 3
Kunming 3
Pune 3
Shanghai 3
Taiyuan 3
Chengdu 2
Chiswick 2
Hackney 2
Hangzhou 2
Las Vegas 2
Majadahonda 2
Monza 2
Ningbo 2
Pavia 2
Tokyo 2
Toronto 2
Udine 2
Wandsworth 2
Washington 2
Aarhus 1
Ankara 1
Auckland 1
Baotou 1
Bari 1
Borås 1
Brendola 1
Brussels 1
Casoria 1
Changchun 1
Chongqing 1
Dunedin 1
Esslingen am Neckar 1
Forlì 1
Fuzhou 1
Hamilton 1
Hounslow 1
Indiana 1
Inverness 1
Johannesburg 1
Kharkiv 1
Legnaro 1
London 1
Manchester 1
Marano Vicentino 1
Marcallo con Casone 1
Memphis 1
Milan 1
Monselice 1
Mumbai 1
New Bedfont 1
New Delhi 1
Newcastle upon Tyne 1
North York 1
Norwalk 1
Ogden 1
Totale 3.300
Nome #
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 157
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 143
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 142
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 139
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 135
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis 116
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? 115
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 113
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 112
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 111
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 109
Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis. 105
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 104
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? 103
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome 101
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. 97
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. 95
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. 93
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae 93
Why and how to measure renal function in patients with liver disease 92
The liver: Another organ involved in Muir Torre syndrome? 92
Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be". 90
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 90
Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis. 89
Terlipressin given by continuous i.v. infusion versus i.v. boluses in the treatment of hepatorenal syndrome: A randomized controlled study. 88
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. 80
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 80
How to improve care in outpatients with cirrhosis and ascites: A new model of care coordination by consultant hepatologists. 76
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis 75
Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer 68
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis 66
Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir 65
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial 64
Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure 64
Garlic extract prevents CCl4-induced liver fibrosis in rats: The role of tissue transglutaminase 64
The liver: Another organ involved in Muir Torre syndrome? 63
Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins 63
Natural history of acute kidney disease in patients with cirrhosis 52
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: Clinical and virological outcomes 44
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge. 38
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis. 36
Bacterial infections in cirrhosis: epidemiology and prevalence of antibiotic resistence, a restrospective monocentric study 35
Hepatocarcinoma in chronic viral hepatitis: from epidemiological data, through new pathophysiological findings, up to new possible clinical tools 19
Totale 3.776
Categoria #
all - tutte 12.472
article - articoli 12.142
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019346 0 0 0 0 0 0 0 0 0 72 147 127
2019/2020897 102 43 22 62 95 67 132 97 106 87 55 29
2020/2021698 35 43 28 41 26 43 34 54 73 151 96 74
2021/2022717 16 87 97 41 42 35 71 77 50 11 60 130
2022/2023509 96 61 13 66 64 85 1 30 62 2 28 1
2023/2024204 10 38 31 30 21 29 20 17 3 5 0 0
Totale 3.776